MODERN ASPECTS OF EPIDEMIOLOGY OF ANKYLOSING SPONDYLOARTHRITIS. REVIEW.
Relevance. Ankylosing spondylitis (AS) is a chronic systemic inflammatory disease of the axial skeleton and iliosacral joints, which is predominantly detected in males. AS affects people of different races and geographic areas, but there is a high disease incidence in certain populations. People suffering from AS experience not only an increased fatality rate compared to the general population, but also a high invalidity level, which leads to a large number of disabilities. Thus, the study of AS peculiarities is an urgent problem of modern medicine.
Aim: To identify the features of the AS epidemiology at the present stage.
Search strategy: A search for scientific publications was carried out in the following databases of scientific publications and specialized search engines: PubMed, Google Scholar, Web of Science, Cyberleninka. Records’ number identified from databases, publicly available on the study topic, various in the design amounted to 352. 316 publications were excluded from the analysis according to the exclusion criteria. Only original publications were analyzed, including meta-analyses, systematic reviews, cohort and cross-sectional studies. The initial search depth was 7 years. 36 publications were selected. Due to the insufficient number of scientific papers and the not so significant prevalence of this disease, the group of authors decided to increase the search depth to 15 years according to the same criteria. 71 scientific papers were selected, which are presented in this literary review.
Results and conclusions: review revealed that the AS prevalence fluctuates in different world regions and depends on the frequency of the HLAB27 gene presence. Literature analysis demonstrates a tendency to increase and more frequent AS detection among the female population in recent decades. At the same time, there is a significant delay in diagnosis in women compared to men, which leads to a significant deterioration in the quality of life due to the late start of treatment.
Aigerim S. Abuova1, https://orcid.org/0000-0001-6796-788X
Assel M. Meiramova1, https://orcid.org/0000-0002-4030-0783
Dinara Z. Sadykova1, https://orcid.org/0000-0003-3834-5648
Zhanar B. Akhmetova1, https://orcid.org/0000-0001-9220-5596
Yelena A. Rib1, https://orcid.org/0000-0001-6265-8121
1 NCJSC "Astana Medical University", Astana, Republic of Kazakhstan.
1. Отчетная документация по форме 12 Министерства Здравоохранения Республики Казахстан за 2018 год. URL: http://ezdrav.kz. (Дата обращения: 28.07.2023).
2. Akkoç N., Yarkan H., Kenar G., Khan M.A. Ankylosing Spondylitis: HLA-B*27 - Positive Versus HLA - B*27-NegativeDisease // Curr Rheumatol Rep. 2017. N 19(5). doi: 10.1007/s11926-017-0654-8.
3. Albrecht K., Binder S., Minden K., Poddubnyy D., Regierer A.C., Strangfeld A., Callhoff J. Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany // Z Rheumatol. Published online February 7, 2023. doi: 10.1007/s00393-022-01302-5
4. Arévalo M., Gratacós Masmitjà J., Moreno M., Calvet J., Orellana C., Ruiz D., Castro C., Carreto P., Larrosa M., Collantes E., Font P. Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: Results from the REGISPONSER database // Arthritis Res Ther. 2018. N 20(1). doi: 10.1186/s13075-018-1724-7.
5. Bakland G., Gran J.T., Nossent J.C. Increased mortality in ankylosing spondylitis is related to disease activity // Ann Rheum Dis. 2011; N 70(11). P. 1921-1925.
6. Barnabe C., Jones C.A., Bernatsky S., Peschken C.A., Voaklander D., Homik J., Crowshoe L.F.et al. Inflammatory Arthritis Prevalence and Health Services Use in the First Nations and Non–First Nations Populations of Alberta, Canada // Arthritis Care Res (Hoboken). 2017. N 69(4). P. 467-474.
7. Baysal Ö., Durmuş B., Ersoy Y., Altay Z., Şenel K., Nas K., Uğur M., Kaya A., et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis // Rheumatol Int. 2011. N 31(6). P. 795-800.
8. Braun J., Sieper J.Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis // RMD Open. 2023, N 9(3). P. e003102.
9. Castillo‐Ortiz J.D., Ramiro S., Landewé R., van der Heijde D., Dougados M., van den Bosch F., Boonen A. Work Outcome in Patients With Ankylosing Spondylitis: Results From a 12-Year Followup of an International Study // Arthritis Care Res (Hoboken). 2016. N 68(4). P. 544-552.
10. Chang C.C., Chang C.W., Nguyen P.A.A., Chang T.H.et al. Ankylosing spondylitis and the risk of cancer // Oncol Lett. 2017. N 14(2). P. 1315-1322.
11. Chaudhary H., Bohra N., Syed K., Donato A., Murad M.H., Karmacharya P. All‐Cause and Cause‐Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta‐Analysis // Arthritis Care Res (Hoboken). 2023. N. 75(5). P. 1052-1065.
12. Chen H.H., Chen Y.M., Lai K.L., Hsieh T.Y., Hung W.T., Lin C.T., et al. Gender difference in ASAS HI among patients with ankylosing spondylitis // PLoS One. 2020. N 15(7). P.e0235678.
13. Chung H.Y., Machado P., van der Heijde D., D’Agostino M.A., Dougados M. HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis // Ann Rheum Dis. 2011. N 70(11). P. 1930-1936.
14. Citera G., Bautista-Molano W., Peláez-Ballestas I., Azevedo V.F., Perich R.A., Méndez-Rodríguez J.A., Cutri M.S., Borlenghi C.E. Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis // Advances in Rheumatology. 2021. N 61(1). doi: 10.1186/s42358-020-00161-5.
15. Cooksey R., Husain M.J., Brophy S., Davies H., Rahman M.A., Atkinson M.D., Phillips C.J., Siebert S. The cost of ankylosing spondylitis in the UK using linked routine and patient-reported survey data // PLoS One. 2015. N. 10(7). P. e0126105.
16. Costantino F., Talpin A., Said-Nahal R., Goldberg M., Henny J., Chiocchia G., Garchon H.J., Zins M., Breban M. Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: Results of the GAZEL cohort // Ann Rheum Dis. 2015. N 74(4). P. 689-693.
17. Curtis J.R., Harrold L.R., Asgari M.M., Deodhar A., Salman C., Gelfand J.M., Wu J.J., Herrinton L.J. Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting // Perm J. 2016. N 20(4). P. 4-10.
18. Dean L.E., Jones G.T., Macdonald A.G., Downham C., Sturrock R.D., Macfarlane G.J. Global prevalence of ankylosing spondylitis // Rheumatology (United Kingdom). 2014. N. 53(4). P. 650-657.
19. Deng C., Li W., Fei Y., Li Y., Zhang F. Risk of malignancy in ankylosing spondylitis: A systematic review and meta-Analysis // Sci Rep. 2016. N. 6. doi: 10.1038/srep32063.
20. Erdes S.F., Balabanova R.M. Ankylosing spondylitis morbidity trends in Russia and Saturday spondyloarthritis schools // Rheumatology Science and Practice. 2013. N 0(2). P. 145-149.
21. Fabreguet I., Koumakis E., Burki V., Durnez A., Elhai M., Meyer M.et al. Assessment of work instability in spondyloarthritis: a cross-sectional study using the ankylosing spondylitis work instability scale // Rheumatology. 2012. N. 51(2). P. 333-337.
22. Franke L.C., Ament A.J.H.A., van de Laar M.A.F.J., Boonen A., Severens J.L Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis // Clin Exp Rheumatol. 2009. N. 27(4 Suppl 55). P. 118-123.
23. Gu Z., Xu X., Shen B., Zhang A., Liu J., Da Z., Liu H. Anxiety and depression correlate with disease and quality-of-life parameters in Chinese patients with ankylosing spondylitis // Patient Prefer Adherence. 2016. N. 10. P. 879-85.
24. Hanson A., Brown M.A. Genetics and the Causes of Ankylosing Spondylitis // Rheumatic Disease Clinics of North America. 2017. N. 43(3). P. 401-414.
25. van der Horst-Bruinsma I.E., Zack D.J., Szumski A., Koenig A.S. Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies // Ann Rheum Dis. 2013. N. 72(7). P. 1221-1224.
26. Hwang M.C., Ridley L., Reveille J.D. Ankylosing spondylitis risk factors: a systematic literature review // Clin Rheumatol. 2021. N. 40(8). P. 3079-3093.
27. Ibn Yacoub Y., Amine B., Laatiris A., Hajjaj-Hassouni N. Gender and disease features in Moroccan patients with ankylosing spondylitis // Clin Rheumatol. 2012. N. 31(2). P. 293-297.
28. Karatekin B.D., Icagasioglu A., Oguz F.M., Bayindir S.N., Pasin O. Trajectory of Anxiety, Depression and Quality of Life in Ankylosing Spondylitis: A Descriptive Study. // J Coll Physicians Surg Pak. 2023. N. 33(3). P. 314-318.
29. Karmacharya P., Shahukhal R., Ogdie A. Risk of Malignancy in Spondyloarthritis: A Systematic Review // Rheumatic Disease Clinics of North America. 2020. N. 46(3). P. 463-511.
30. Kim H.W., Choe H.R., Lee S. Bin, Chang W.I., Chae H.J., Moon J.Y., Kang J., Lee S., Song Y.W., Lee E.Y. Phenotype Difference between Familial and Sporadic Ankylosing Spondylitis in Korean Patients // J Korean Med Sci. 2014. N. 29(6). P. 782-795.
31. Kim J.H., Choi I.A. Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta-analysis // Int J Rheum Dis. 2021. N. 24(4). P. 477-486.
32. Kim T.J., Sung I.H., Lee S., Joo K. Bin, Choi J.H., Park D.J., Park Y.W., Lee S.S., Kim T.H. HLA-B27 homozygosity has no influence on radiographic damage in ankylosing spondylitis: Observation Study of Korean spondyloArthropathy Registry (OSKAR) data // Joint Bone Spine. 2013. N. 80(5). P. 488-491.
33. Krüger K., von Hinüber U., Meier F., Tian H., Böhm K., Jugl S.M., Borchert K., Meise D., König C., Braun S. Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis // Rheumatol Int. 2018. N. 38(11). P. 2121-2131
34. Kwon S.R., Kim T.H., Kim T.J., Park W., Shim S.C. The Epidemiology and Treatment of Ankylosing Spondylitis in Korea // Journal of Rheumatic Diseases. 2022. N. 29(4). P. 193-199.
35. Lee T.J., Park B.H., Kim J.W., Shin K., Lee E.B., Song Y.W. Cost-of-illness and quality of life in patients with ankylosing spondylitis at a tertiary hospital in Korea // J Korean Med Sci. 2014. N. 29(2). P. 190-197.
36. Lu M.C., Huang K.Y., Tung C.H., Hsu B.B., Wu C.H., Koo M., Lai N.S. Factors associated with disease-specific quality of life in Taiwanese patients with ankylosing spondylitis: A cross-sectional study // BMJ Open. 2019. N. 9(6). P. e028966.
37. Malhan S., Pay S., Ataman S., Dalkilic E., Dinc A., Erken E., Ertenli I., Ertugrul E., Gogus F. et al. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey // Clin Exp Rheumatol. 2012. N. 30(2). P. 202-207.
38. Malinowski K.P., Kawalec P. The indirect costs of ankylosing spondylitis: a systematic review and meta-analysis // Expert Rev Pharmacoecon Outcomes Res. 2015. N. 15(2). P. 285-300.
39. Martindale J., Shukla R., Goodacre J. The impact of ankylosing spondylitis/axial spondyloarthritis on work productivity // Best Pract Res Clin Rheumatol. 2015. N. 29(3). P. 512-523.
40. Merino M., Braçe O., González-Domínguez A., Hidalgo-Vega Á., Garrido-Cumbrera M., Gratacós J. Social economic costs of ankylosing spondylitis in Spain // Clin Exp Rheumatol. 2021. N. 39(2). P. 357-364.
41. Nam B., Koo B.S., Nam S.W., Shin J.H., Song Y., Cho S.K., Sung Y.K., Kim T.H. Gender differences in factors associated with low quality of life and depression in Korean patients with ankylosing spondylitis // Quality of Life Research. 2021. N. 30(8). P. 2299-2310.
42. Nazarinia M.A., Ghaffarpasand F., Heiran H.R., Habibagahi Z. Pattern of ankylosing spondylitis in an Iranian population of 98 patients // Mod Rheumatol. 2009. N. 19(3). P. 309-315.
43. Nygaard A., Ljungdalh P.S., Iachina M., Nikolov T.N., Schiøttz-Christensen B. Incidence of ankylosing spondylitis and spondyloarthritis in 2000–2013: a nationwide Danish cohort study // Scand J Rheumatol. 2020. N. 49(1). P. 21-27.
44. Park J.S., Hong J.Y., Park Y.S., Han K., Suh S.W. Trends in the prevalence and incidence of ankylosing spondylitis in South Korea, 2010-2015 and estimated differences according to income status // Sci Rep. 2018. N. 8(1). P. 7694.
45. Peláez-Ballestas I., Sanin L.H., Moreno-Montoya J., Alvarez-Nemegyei J.et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology // Journal of Rheumatology. 2011. N. 8(SUPPL. 86). P. 3-6.
46. Perrone V., Losi S., Filippi E., Antonelli S., Giovannitti M., Giacomini E., Sangiorgi D., Degli Esposti L. Analysis of the prevalence of ankylosing spondylitis and treatment patterns and drug utilization among affected patients: an Italian real-world study // Expert Rev Pharmacoecon Outcomes Res. 2022. N. 22(2). P. 327-333.
47. Prati C., Claudepierre P., Pham T., Wendling D. Mortality in spondylarthritis // Joint Bone Spine. 2011. N. 78(5). P. 466-470.
48. Ramonda R., Marchesoni A., Carletto A., Bianchi G., Cutolo M., Ferraccioli G. et al.Mortality in spondylarthritis // Joint Bone Spine. 2011. N. 78(5). P. 466-470.
49. Rashid T., Wilson C., Ebringer A. Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption // Rheumatol Int. 2015. N. 35(6). P. 945-951.
50. Reveille J.D., Maganti R.M. Subtypes ofHLA-B27: History and Implications in the Pathogenesis of Ankylosing Spondylitis // Adv Exp Med Biol. 2009. N. 649. P. 159-176
51. Reyes-Llerena G.A., Guibert-Toledano M., Penedo-Coello A., et al. Community-based study to estimate prevalence and burden of illness of rheumatic diseases in cuba: A COPCORD study // Journal of Clinical Rheumatology. 2009. N. 15(2). P. 51-55.
52. Rustagi T., Drazin D., Oner C., York J., Schroeder G.D., Vaccaro A.R., Oskouian R.J., Chapman J.R. Fractures in Spinal Ankylosing Disorders: A Narrative Review of Disease and Injury Types, Treatment Techniques, and Outcomes // J Orthop Trauma. 2017. N. 31. P. 57-74.
53. Saǧ S., Nas K., Saǧ M.S., Tekeoǧlu I., Kamanll A. Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis // J Back Musculoskelet Rehabil. 2018. N. 31(3). P. 499-505.
54. Shahlaee A., Mahmoudi M., Nicknam M.H., Farhadi E., Fallahi S., Jamshidi A.R. Gender differences in Iranian patients with ankylosing spondylitis // Clin Rheumatol. 2015. N. 34(2). P. 285-293
55. Stolwijk C., van Onna M., Boonen A., van Tubergen A. Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-Regression Analysis // Arthritis Care Res (Hoboken). 2016. N. 68(9). P. 1320-1331.
56. Strömbeck B., Englund M., Bremander A., Jacobsson L.T.H., Kedza L., Kobelt G., Petersson I.F. Cost of illness from the public payers’ perspective in patients with ankylosing spondylitis in rheumatological care // Journal of Rheumatology. 2010. N. 37(11). P. 2348-2355.
57. Tikly M., Njobvu P., McGill P. Spondyloarthritis in sub-Saharan Africa // Curr Rheumatol Rep. 2014. N. 16(6). P. 421-427.
58. Tłustochowicz M., Brzozowska M., Wierzba W., Raciborski F., Kwiatkowska B., Tłustochowicz W., Jacyna A., Marczak M., Kisiel B., Śliwczyński A. Prevalence of axial spondyloarthritis in Poland // Rheumatol Int. 2020. N. 40(2). P. 323-330.
59. Torres T.M., Ferraz M.B., Ciconelli R.M. Resource utilisation and cost of ankylosing spondylitis in Brazil // Clin Exp Rheumatol. 2010. N. 28(4) P. 490-497.
60. Tu L., Rai J., Cao S., Lin Z., Hu Z., Gu J., Tu. Costs and Work Limitation of Patients with Ankylosing Spondylitis in China // Clin Exp Rheumatol. Vol 32.; 2014. N. 32(5). P. 6-11.
61. Tuncer T. Prevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study // Arch Rheumatol. 2018. N. 33(2). P. 128-136.
62. Uludag M., Unalan H., Tuzun S., Kocabasoglu N., Aydin F.Y., Palamar D., Ozdemir S., Akarirmak U. Assessment of quality of life and depression in spouses of patients with ankylosing spondylitis // Rheumatol Int. 2012. P. 32(11). P. 3511-3516.
63. Usenbo A., Kramer V., Young T., Musekiwa A. Prevalence of arthritis in Africa: A systematic review and meta-analysis // PLoS One. 2015. N. 10(8). P. e0133858.
64. Voruganti A., Bowness P. New developments in our understanding of ankylosing spondylitis pathogenesis // Immunology. 2020. N. 161(2). P. 94-102.
65. Wang R., Ward M.M. Epidemiology of axial spondyloarthritis: An update // Curr Opin Rheumatol. 2018. N. 30(2). P. 137-143.
66. Ward M.M., Alehashemi S. Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis // Rheumatology. 2020. N. 59(12). P. 3817-3825.
67. Wright G.C., Kaine J., Deodhar A. Understanding differences between men and women with axial spondyloarthritis // Semin Arthritis Rheum. 2020. N. 50(4). P. 687-694.
68. Yang M., Xu M., Pan X., Hu Z., Li Q., Wei Y., Zhang Y., Rong J.et al. Epidemiological comparison of clinical manifestations according HLA-B27(+) and HLA-B27(-) carrier status of Chinese Ankylosing Spondylitis patients // Tissue Antigens. 2013. N. 82(5). P/ 338-343.
69. Zhao J., Huang C., Huang H., Pan J.Ke, Zeng L.Feng, et al.Prevalence of ankylosing spondylitis in a Chinese population: a systematic review and meta-analysis // Rheumatol Int. 2020. N. 40(6). P. 859-872.
70. Zhao S.S., Robertson S., Reich T., Harrison N.L., Moots R.J., Goodson N.J. Prevalence and impact of comorbidities in axial spondyloarthritis: Systematic review and meta-analysis // Rheumatology (United Kingdom). 2020. N. 59. P. 47-57.
71. Zhu T.Y., Tam L.S., Lee V.W.Y., Hwang W.W., Li T.K., Lee K.K., Li E.K. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong // Rheumatology. 2008. N. 47(9). P. 1422-1425.
References: [1]
1. Otchetnaya dokumentatsiya po forme 12 Ministerstva Zdravookhraneniya Respubliki Kazakhstan za 2018 god [Reporting documentation according to Form 12 of the Ministry of Health of the Republic of Kazakhstan for 2018]. http://ezdrav.kz. (accessed: 28.07.2023). [in Russian]
Количество просмотров: 422
Категория статей:
Обзор литературы
Библиографическая ссылка
Abuova A.S., Meiramova A.M., Sadykova D.Z., Akhmetova Zh.B., Rib Ye.A. Modern aspects of epidemiology of ankylosing spondyloarthritis. Review // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 6, pp. 199-206. DOI 10.34689/SH.2023.25.6.023Похожие публикации:
UNDERSTANDING OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN AT THE PRESENT STAGE. REVIEW.
ГЕМОДИНАМИЧЕСКИ ЗНАЧИМЫЙ ОТКРЫТЫЙ АРТЕРИАЛЬНЫЙ ПРОТОК У НЕДОНОШЕННЫХ НОВОРОЖДЕННЫХ ДЕТЕЙ. ОБЗОР ЛИТЕРАТУРЫ
RADIOIODINE-RESISTANT DIFFERENTIATED THYROID CANCER: CLINICOPATHOLOGICAL CHARACTERISTICS, MOLECULAR GENETIC ALTERATIONS. REVIEW.
ПРЕРЫВИСТАЯ КАТЕТЕРИЗАЦИЯ МОЧЕВОГО ПУЗЫРЯ КАК «ЗОЛОТОЙ СТАНДАРТ» ЛЕЧЕНИЯ НЕЙРОГЕННОГО МОЧЕВОГО ПУЗЫРЯ У ЛИЦ, С ПОВРЕЖДЕНИЕМ СПИННОГО МОЗГА
АНАЛИЗ ОПЫТА МЕДСЕСТЕР И ФАКТОРОВ, ВЛИЯЮЩИХ НА ДОБРОВОЛЬНОЕ СООБЩЕНИЕ ОБ ИНЦИДЕНТАХ